Clinical Evaluation of Eltrombopag in Chronic Idiopathic Thrombocytopenic Purpura (ITP)

Clinical trial NCT00828750 · COMPLETED

Trial details

NCT number: NCT00828750
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Idiopathic Thrombocytopenic Purpura Purpura, Thrombocytopenic, Idiopathic

Start date: 2008-05-01
Primary completion: 2011-02-01
Enrollment: 19

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.